title: [Psychogenic erectile dysfunction and phosphodiesterase inhibitors type 5].
abstract: In the literature, much of the attention is focused on the organic erectile dysfunction (ED) rather than on psychogenic one. This article analyses the causes and mechanisms of psychogenic ED. It outlines the issues of diagnosis, therapy and specific features of using phosphodiesterase inhibitors type 5 in the management of psychogenic ED.
authors.affiliation: Department of Urology A.I. Evdokimov Moscow State University of Medicine and Dentistry.
authors.forename: D Yu
authors.initials: DY
authors.lastname: Pushkar
authors.affiliation: Department of Urology A.I. Evdokimov Moscow State University of Medicine and Dentistry.
authors.forename: A S
authors.initials: AS
authors.lastname: Segal
mesh_terms: D003131:Combined Modality Therapy; D007172:Erectile Dysfunction / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000628:therapy*; D006801:Humans; D008297:Male; D058986:Phosphodiesterase 5 Inhibitors / Q000627:therapeutic use*; D011613:Psychotherapy / Q000379:methods*
chemical_list: D058986:Phosphodiesterase 5 Inhibitors
keywords: PDEI-5; psychogenic erectile dysfunction; psychotherapy